Tuesday, October 15, 2019

Canada's Cannabis Industry: The Industry's Bre-X Moment, Valuations, Biological Assets Accounting and Missed Financial Results

In biting my tongue during the last weeks of Canadian election campaigning (the leaders' gaffes, debates, "accredited" and unaccredited media coverage and exponentially more social media coverage speak for themselves) I have refrained from adding to the internet's traffic and storage space.  My mind has been made up and as of Friday October, 11th I voted with that.

In the meantime, I have been watching the cannabis industry.  As predicted on this blog previously, the bubble has not burst but is deflating.  We have had our Bre-X moment in the cannabis industry of "the gold is there"; however, was fraudulently grown versus fraudulently portrayed.  Valuations have come down from the stratosphere (see: FSD Pharma, HUGE:CSE - yes, you read that ticker symbol correctly).  The financial results have been a shock of reality for investors with the hope of edibles later this year becoming the industry's saviour.

Perhaps the only cure for the industry, like many other ailments, may be itself - CBD and THC.

https://business.financialpost.com/cannabis/cannabis-news/cannabis-legalization/a-year-in-the-weeds-why-the-cannabis-industry-didnt-take-off-the-way-everyone-planned?video_autoplay=true

No comments:

Post a Comment